MicroRNA Profiling for Diagnosis of Dysplastic Nevi and Melanoma
Copyright © Targeted News Service 2024
2024-04-16
ALEXANDRIA, Virginia, April 16 -- QUEST DIAGNOSTICS INVESTMENTS LLC, Secaucus, New Jersey has been assigned a patent (No. US 11959143 B2, initially filed Nov. 24, 2020) developed by five inventors Kevin Qu, Lake Forest, California; Anthony Sferruzza, San Clemente, California; Ke Zhang, San Clemente, California; Yan Liu, San Juan Capistrano, California; and Renius Owen, San Juan Capistrano, California, for "MicroRNA profiling for diagnosis of dysplastic nevi and melanoma." . . .